Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

NCT00365820 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
670
Enrollment
INDUSTRY
Sponsor class

Stopped This study was terminated early as a result of regulatory action suspending tegaserod use in 2007

Conditions

Interventions

Sponsor

Novartis